AZA + Glutaminase Inhibition with Telaglenastat (CB-839) for Advanced MDS: An Updated Interim Analysis
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Kapil Saxena, Marina Konopleva, Tushar D Bhagat, Veronica A Guerra, Rita Maduike, Stefano Tiziani, Gautam Borthakur, Elias Jabbour, Naveen Pemmaraju, Tapan M. Kadia, Nicholas J. Short, Jan A. Burger, Steven M. Kornblau, Naval Daver, Kiran Naqvi, Tianyu Cai, Vinitha Mary Kuruvilla, Hagop M. Kantarjian, Guillermo Garcia-Manero, Amit Verma, Courtney D. DiNardo
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097437938